Welcome New Faculty 2022

updated: 29.09.2022

Welcome new faculty members

Dr. Yaara Oren is a new faculty member in the Department of Human Molecular Genetics and Biochemistry in the Faculty of Medicine. Dr. Oren completed her doctoral studies in the Department of Microbiology and Cell Research at Tel Aviv University. She then continued her post-doctoral studies in collaboration between Harvard Medical School and Broad, a joint research institute of Harvard and MIT. Dr. Oren was awarded a postdoctoral fellowship from the HOPE Foundation for the study of hard-to-treat cancers, as well as a research fellowship from the Rivkin Foundation for ovarian cancer research. Dr. Oren's research investigates a rare population of cancer cells, called persister cells, which are able to evade the drugs without acquiring a genetic mutation. These cells are probably at the root of our inability to cure cancer even when it is possible to treat the patient with a drug that matches the genetic code of their cancer. Despite the great clinical importance of understanding the processes that enable the survival of persister cells, their rarity and the difficulty of characterizing them have hampered the development of treatments that target them. Dr. Oren's research combines single-cell experimental and computational tools to shed light on the processes that enable persister cells to survive treatment. Dr. Oren hopes that the research being carried out in her laboratory will serve as a basis for the development of drugs that will kill this deadly cell population.


Dr. Noa Lamm, PhD, is a new faculty member at the Department of Human Molecular Genetics and Biochemistry in the School of Medicine of the Faculty of Medicine. Dr. Lamm earned her PhD from the Department of Genetics at the Hebrew University. She then completed a short post-doctoral training at the Hebrew University before moving to a second fellowship at the Children's Medical Research Institute (CMRI) in Sydney, Australia. Dr. Lamm received the Israeli Cancer Research Fund (ICRF) post-doctoral fellowship and the Cancer Institute NSW Early Career Fellowship. Dr Lamm's research investigates the structural, architectural, and physical nuclear alterations that occur in response to replication stress and how these alterations facilitate the regulation of DNA repair in time and space. Replication stress is a hallmark of cancer; therefore, understanding how cancer cells resist is highly important. Dr. Lamm utilizes diverse experimental approaches and various techniques, including biochemistry, proteomics, live-cell imaging, super-resolution microscopy, bespoke image analysis tools and DNA combing analysis to gain conceptual advances in nuclear biology. Her research seeks to combine basic research with translational approaches to identify, validate, and target specific regulators of nuclear dynamics to eliminate cancer.


Dr. Mor Saban, PhD, is a new faculty member in the Department of Nursing at the School of Health Professions of the Faculty of Medicine. She also serves as a senior researcher in the Center for Technology Assessment in Health Care at the Gertner Institute of Epidemiology and Health Policy Research. Dr. Saban holds a B.A. degree in nursing, three Master’s degrees (MA, MPH, MEM) with an emphasis in emergency management and health policy, and a PhD in the field of clinical decision-making in an emergency setting from Haifa University. She completed a post-doctoral fellowship in the Department of Health System Management at Ben-Gurion University. She continued her studies in data science with a specialization in machine learning at Bar-Ilan University.  Dr. Saban's research emphasis is on clinical decision-making in medicine and the impact of using decision-support technologies on decision-making processes. Furthermore, her research focuses on improving health policy, such as developing a methodology for measuring waiting times for elective procedures and developing optimization models for resource allocation in health systems. At the Gertner Institute, Dr. Saban was the Director of National Hospital Waiting Time Measurement and led a national project for implementing a clinical decision support system in radiology.


Dr. William Saban (Will), Ph.D., is a new faculty member in the Department of Occupational Therapy at the School of Health Professions of the Faculty of Medicine. Dr. Saban completed his Clinical Neuropsychology Ph.D. studies at the University of Haifa, Department of Psychology. Then, he completed his postdoctoral training at the University of California Berkeley, Department of Psychology, and the Helen Wills Neuroscience Institute, where he received the prestigious Rothschild Fellowship. In his research, Dr. Saban explores the uncharted territory of subcortical brain areas that are hypothesized to influence cognition. To date, he has utilized complementary methodological approaches regarding 1) lesion studies, 2) healthy humans using stereoscopic manipulation, and 3) comparative neuroscience using archerfish to investigate how the subcortex supports cognition (e.g., attention, arithmetic, sequence learning).


At present, Dr. Saban is focused on utilizing neuropsychological approaches to examine the role of the cerebellum and basal ganglia in cognition. For this work, he tests patients with degenerative disorders of the cerebellum (cerebellar degeneration) or the basal ganglia (Parkinson’s disease). To facilitate patient studies, he has developed and implemented a novel online platform for conducting neuropsychological research (PONT) in the USA. Dr. Saban is also developing iPONT: an Israeli Platform for Online Neuropsychological Testing, a joint venture between Tel Aviv University and the Tel-Aviv Sourasky Medical Center, specializing in remote neuropsychological testing for individuals with neurological abnormalities such as Parkinson's disease, spinocerebellar ataxia, and dyslexia. The main advantage of remote neuropsychological testing is the vast amount of data we can collect quickly. Dr. Saban’s research identifies risk factors and cognitive markers for these neurological abnormalities. With these large data sets, by utilizing computational models and machine learning algorithms, he aims to better map the subtypes and progression of these diseases, leading to improved earlier detection and cognitive interventions.



Dr. Tony Gutentag joins the Department of Medical Education this year as a Senior Lecturer. Dr. Gutentag completed a B.A., M.A., Ph.D., and M.B.A., all Magna Cum Laude at the Hebrew University of Jerusalem. She completed her post-doctoral training in educational psychology at the Hebrew University, and in psychology at the University of Toronto and at the University of Melbourne. Dr. Gutentag studies social and emotional aspects in education in general, and in medical education in particular. For example, in what way can we help physicians to be more empathic toward their patients? How can we attenuate burnout among healthcare professionals? Can we improve medical students’ learning by using academically productive talk? Dr. Gutentag’s research is interdisciplinary, combining psychology, organizational behavior, education, and psychometrics, and uses multi-method (e.g., experiments, surveys, experience sampling). Google scholar; ResearchGate; Twitter; Email

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>